» Articles » PMID: 39225786

Justifying Access to Kidney Care in Low Resource and Humanitarian Settings

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: Access to and quality of kidney care is not equitable between or within countries. A natural question is whether global kidney care inequities are always unjustifiable and unfair, or are sometimes due to unavoidable competing or conflicting ethical duties or responsibilities.

Recent Findings: Health is a fundamental right for all people. People with kidney conditions should have the same claim on this human right as others. Countries have an obligation to progressively fulfil this right and a duty to do so equitably, but global progress has been slow. Countries with limited resources or faced with humanitarian emergencies must set priorities to allocate resources fairly. This process involves trade-offs and often people requiring kidney replacement therapy are left out because of costs, logistics and lack of data. Major burdens are placed on clinicians who grapple between their duty to their patient and professional codes and their responsibility to a 'greater good'. These dilemmas apply also to industry, governments and the international community who must recognize their share in these duties.

Summary: Inequities in kidney health and care must be acknowledged and sustainable and collaborative solutions urgently found such that right to kidney care is progressively upheld for everyone everywhere.

References
1.
Hunt M, Schwartz L, Sinding C, Elit L . The ethics of engaged presence: a framework for health professionals in humanitarian assistance and development work. Dev World Bioeth. 2013; 14(1):47-55. DOI: 10.1111/dewb.12013. View

2.
Uberoi D, Forman L . What Role Can the Right to Health Play in Advancing Equity in Kidney Care?. Semin Nephrol. 2021; 41(3):220-229. DOI: 10.1016/j.semnephrol.2021.05.003. View

3.
Tuglular S, Luyckx V . Maintaining kidney replacement therapy during armed conflicts. Nephrol Dial Transplant. 2023; 39(5):735-738. DOI: 10.1093/ndt/gfad259. View

4.
Hassan H, Hafez M, Luyckx V, Tuglular S, Abu-Alfa A . Kidney failure in Sudan: thousands of lives at risk. Lancet. 2023; 402(10402):607. DOI: 10.1016/S0140-6736(23)01370-3. View

5.
Emanuel E, Buchanan A, Chan S, Fabre C, Halliday D, Heath J . What are the obligations of pharmaceutical companies in a global health emergency?. Lancet. 2021; 398(10304):1015-1020. PMC: 8342311. DOI: 10.1016/S0140-6736(21)01378-7. View